Replies to post #46635 on Innovation Pharmaceuticals Inc (IPIX)

[MrW]

BI is covering costs for K with PFE drugs. CTIX does have costs for the DF trial. This PR details it:

http://cellceutix.com/cellceutix-arranges-1-million-financing-for-clinical-trials-of-new-cancer-drug-ind-filing-imminent-2/

[petemantx]

I would have sworn we discussed this item on this board and CTIX is paying for the Kevetrin trials. I thought DF was picking up some of the BI work costs.

In the S-3 form posted today (?) it specifically states CTIX has budgeted $1.35MM for Kevetrin phase 1 trial on pg 17 under Risk Factors, Risks Specific to Us, Clinical Trials.